Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime (Q28212769)

https://api.crossref.org/works/10.1038/NM1102-1211

The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein

22 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1102-1211

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

22 April 2017

1 reference

https://api.crossref.org/works/10.1038/NM1102-1211

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

22 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

The pathogenesis of atherosclerosis: a perspective for the 1990s

22 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

22 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

22 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

The cholesterol controversy is over. Why did it take so long?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Pleiotropic effects of statins and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Quantitative assessment of atherosclerotic lesions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

The combined role of P- and E-selectins in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Uptake and degradation of low density lipoprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Purification and characterization of a bovine acetyl low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

The response-to-retention hypothesis of early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

The role of oxidized lipoproteins in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

The pathogenesis of atherosclerosis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

The pathogenesis of atherosclerosis (second of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Atherosclerosis. the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Bioactive phospholipid oxidation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Oxidized LDL activates fas-mediated endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Oxidized-LDL induced changes in membrane physico-chemical properties and [Ca2+]i of bovine aortic endothelial cells. Influence of vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Paraoxonase and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Cholesterol reduction yields clinical benefit: impact of statin trials

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

The distribution and composition of serum lipoproteins in eighteen animals

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diet

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Lipoprotein oxidation and lipoprotein-induced cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Induction of murine macrophage growth by modified LDLs

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Enhanced macrophage uptake of low density lipoprotein after self-aggregation

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Scanning electron microscopy in the evaluation of endothelial integrity of the fatty lesion in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: A study based on four serial coronary arteriograms per year

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Inflammatory Platelet-activating Factor-like Phospholipids in Oxidized Low Density Lipoproteins Are Fragmented Alkyl Phosphatidylcholines

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Oxidized low density lipoprotein stimulates collagen production in cultured arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1211

7 January 2021

Identifiers

DOI

10.1038/NM1102-1211

1 reference

Consolidated OpenCitations Corpus – April 2017

2252983

2252983

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference